Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FKRMJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,703
Award facts
- Contract value 100% obligated
- $9,702.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $9,702.75 to DMS Pharmaceutical Group Inc. for the supply of 200-unit vials of Botox. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL, with an ultimate completion date of October 7, 2025. This delivery order was not issued under a set-aside designation and represents a continuation of the agency's pharmaceutical supply operations. The award was made on September 16, 2025.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain through consistent contract performance delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's federal contracting history demonstrates expertise in supplying specialized pharmaceutical products including injectables, oncology treatments, and other medical supplies essential to military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FKRMJ?
SPE2DB25FKRMJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FKRMJ worth?
The government has obligated $9,703 on SPE2DB25FKRMJ.
Is contract SPE2DB25FKRMJ an order under another contract?
Yes. SPE2DB25FKRMJ is a delivery order under SPE2DB24D9314, an indefinite delivery contract.
Was contract SPE2DB25FKRMJ competed?
The extent of competition for SPE2DB25FKRMJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award